Users report faster return to performance after high-volume or eccentric loading cycles
Research is limited, and more is needed to support its role in metabolic health and weight management
Wegovy and Zepbound are FDA approved for weight loss, and Wegovy additionally received approval from the agency to treat cardiovascular conditions in patients with overweight or obesity in March
Dementias of primarily non-cerebral origin are not covered in detail, as their biomarker profiles are distinct, well-characterized, and seldom controversial
Tap water and bottled water are not sterile and contain minerals and impurities that can contaminate and degrade the peptides
Retail prices often exceed $1,000 per month, and even after rebates, estimated net prices for some GLP-1 weight-management therapies still reach $7,400 to $9,190 per patient per year